Viewing Study NCT05972460


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2025-12-27 @ 10:51 PM
Study NCT ID: NCT05972460
Status: UNKNOWN
Last Update Posted: 2023-08-02
First Post: 2023-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: IMM2510, a PD-L1 and VEGF Bispecific Fusion Protein, in Patients With Advanced Solid Tumors
Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module